v3.26.1
Net Loss Per Share
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Earnings Per Share [Abstract]    
Net Loss Per Share
12. Net Loss Per Share
The net loss and the weighted average number of shares of common stock and pre-funded warrants used in computing basic and diluted net loss per share for the three and six months ended June 30, 2026 and 2025, are as follows (in thousands, except share and per share data):
 
     Three Months
Ended June 30,
     Six Months
Ended June 30,
 
     2026      2025      2026      2025  
Numerator:
           
Net loss
   $ (4,502    $ (1,891    $ (8,256    $ (3,600
Denominator:
           
Weighted average number of shares of common stock and pre-funded warrants used in computing net loss per share, basic and diluted
     6,789,165        347,000        5,592,596        346,482  
  
 
 
    
 
 
    
 
 
    
 
 
 
Net loss per share, basic and diluted
   $ (0.66    $ (5.45    $ (1.48    $ (10.39
  
 
 
    
 
 
    
 
 
    
 
 
 
The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as their effect would be anti-dilutive:
 
     Six Months
Ended June 30,
 
     2026      2025  
Options to purchase common stock
     1,048,407        27,038  
Restricted stock units, unvested portion
     2,067        7,020  
Restricted stock awards, unvested portion
     13,067        20,906  
Common warrants
     50,402        50,402  
  
 
 
    
 
 
 
Total potential common stock equivalents
     1,113,943        105,366  
  
 
 
    
 
 
 
The outstanding pre-funded warrants are exercisable for only a de minimis cash consideration with no substantive exercise contingencies, accordingly, the Company included pre-funded warrants in the weighted average shares outstanding for both basic and diluted earnings per share calculations.
12. Net Loss Per Share
The loss and the weighted average number of shares of common stock and pre-funded warrants used in computing basic and diluted net loss per share for the years ended December 31, 2025, 2024, and 2023, are as follows (in thousands, except share and per share data):
 
     Year ended December 31,  
     2025      2024      2023  
Numerator:
        
Net loss
   $ (5,995    $ (3,143    $ (17,054
Denominator:
        
Weighted average number of shares of common stock and pre-funded
warrants used in computing net loss per share, basic and diluted
     1,122,495        341,708        233,670  
Net loss per share, basic and diluted
   $ (5.34 )    $ (9.20 )     $ (72.98 )
The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as their effect would be anti-dilutive:
 
     Year ended December 31,  
     2025      2024      2023  
Options to purchase common stock
     903,096        27,412        28,686  
Restricted stock units
     4,316        4,316        6,818  
Restricted stock awards
     15,683        20,906         
Warrants
     50,402        50,402        36,767  
Total potential common stock equivalents
     973,497        103,036        72,271  
The outstanding pre-funded warrants are exercisable for only a de minimis cash consideration with no substantive exercise contingencies, accordingly, the Company included pre-funded warrants in the weighted average shares outstanding for both basic and diluted EPS calculations.